Earnings calls

ERIS Lifescience concall ledger

Every earnings call for ERIS — management tone, guidance, KPIs and promise tracking, quarter by quarter.

ERIS · 7 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 20 May 2026Call held 20 May 2026

ERIS Q4 FY26 Earnings Call Transcript & Analysis

Reported PAT₹648 cr

Reported PAT (FY26) ₹648 cr. Full year DBF revenue grew 11% to INR 2,778 crores, with EBITDA margin expanding to 37%.

Read full transcript & analysis

Q3 FY26Published 13 Feb 2026Call held 13 Feb 2026

ERIS Q3 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹807 cr+11% YoYConsolidated PAT₹120 cr+40% YoYConsolidated EPS₹9

Consolidated Revenue (Q3) ₹807 cr (+11% YoY); Consolidated PAT (Q3) ₹120 cr (+40% YoY); Consolidated EPS (Q3) ₹9. DBF revenue for 9M FY26 grew 10% YoY to INR 2,106 crores.

Read full transcript & analysis

Q2 FY26Published 12 Nov 2025Call held 12 Nov 2025

ERIS Q2 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹792 crConsolidated EBITDA₹288 crPAT₹134 cr+39% YoYEPS₹10Net Debt₹2,278 cr

Consolidated Revenue ₹792 cr; Consolidated EBITDA ₹288 cr; PAT ₹134 cr (+39% YoY). Consolidated Revenue reached ₹792 crores for Q2, with H1 revenue at ₹1,565 crores.

Read full transcript & analysis

Q1 FY26Published 05 Aug 2025Call held 05 Aug 2025

ERIS Q1 FY26 Earnings Call Transcript & Analysis

Revenue₹773 cr+7% YoYEBITDA Margin36%PAT₹125 cr+41% YoYEPS₹9+41% YoYNet Debt₹2,300 cr

Revenue ₹773 cr (+7% YoY); EBITDA Margin 36%; PAT ₹125 cr (+41% YoY). Consolidated Revenue reached ₹773 crores, representing a 7.4% YoY growth.

Read full transcript & analysis

Q4 FY25Published 19 May 2025Call held 19 May 2025

ERIS Q4 FY25 Earnings Call Transcript & Analysis

Revenue₹705 cr+28% YoYEBITDA₹252 cr+70% YoYEBITDA Margin36%PAT₹102 cr+28% YoYNet Debt₹2,200 cr

Revenue ₹705 cr (+28% YoY); EBITDA ₹252 cr (+70% YoY); EBITDA Margin 36%. Consolidated Revenue for Q4 FY25 reached ₹705 crores, representing a 28% YoY growth.

Read full transcript & analysis

Q3 FY25Published 04 Feb 2025Call held 04 Feb 2025

ERIS Q3 FY25 Earnings Call Transcript & Analysis

Consolidated Revenue₹727 cr+50% YoYConsolidated EBITDA₹250 cr+43% YoYNet Debt₹2,100 cr

Consolidated Revenue ₹727 cr (+50% YoY); Consolidated EBITDA ₹250 cr (+43% YoY); Net Debt ₹2,100 cr. Consolidated operating revenue grew 50% YoY to ₹727 crores in Q3 FY25.

Read full transcript & analysis

Q2 FY25Published 25 Oct 2024Call held 25 Oct 2024

ERIS Q2 FY25 Earnings Call Transcript & Analysis

Revenue₹741 cr+47% YoYEBITDA₹265 cr+46% YoYEBITDA Margin35.7%Net Debt₹2,500 crROCE17%

Revenue ₹741 cr (+47% YoY); EBITDA ₹265 cr (+46% YoY); EBITDA Margin 35.7%. Consolidated revenue grew 47% YoY to ₹741 crores; H1 revenue reached ₹1,461 crores (+50% YoY).

Read full transcript & analysis